Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXALT: Extended Duration Artemether-lumefantrine for Malaria
NCT03453840Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Feb 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artemether + lumefantrine in Plasmodium falciparum malaria, sponsored by University of California, San Francisco. Started Feb 2018; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT03453840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03453840.